Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02878590 · ClinicalTrials.gov registry record · NA
Clinical Study for the BONGO Device in the Treatment of Obstructive Sleep Apnea (OSA)
A NA study of Obstructive Sleep Apnea, sponsored by InnoMed Healthscience.
- Completed
- Registry status
- NA
- Development phase
- 23
- Enrollment target
- 1
- Study location
NCT02878590: Completed NA study of Obstructive Sleep Apnea, sponsored by InnoMed Healthscience.
NCT02878590 is a NA study of Obstructive Sleep Apnea that has completed, run by InnoMed Healthscience. The registered enrollment target is 23 participants, below the 221-participant average among 155 other Obstructive Sleep Apnea trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02878590, a NA study of Obstructive Sleep Apnea, has completed, sponsored by InnoMed Healthscience.
- COMPLETED
- Registry status
- NA
- Development phase
- 23 participants
- Enrollment target
- 1
- Study location
Study Summary
Prospective, non-randomized, open label study
Primary Outcome
Obstructive Sleep Apnea (OSA) severity is divided into three categories based on the Apnea-Hypopnea Index (AHI) as follows: Mild (AHI of 5 to 15), Moderate (AHI of 15 to 30), and Severe (AHI \> 30). AHI is calculated by dividing the number of events (i.e. Apneas and hypopneas) by the number of hours of sleep. The primary outcome for the study was change in AHI, defined as the difference in AHI between the diagnostic PSG study (baseline with no device) and the final PSG study with the Bongo devic
Conditions Studied
Interventions
- DEVICE BONGO DEVICE
Study Locations (1)
California
- California Center for Sleep Disorders - Alameda
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2016-09 |
| Est. Completion | 2017-11-30 |
| Phase | NA |
What the finished NCT02878590 record still lists
NCT02878590 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 23 participants, a relatively small participant target, below the 221-participant average among 155 other Obstructive Sleep Apnea trials with a reported enrollment target (90% lower).
The record links to 1 condition, with Obstructive Sleep Apnea appearing as the primary indexed condition, and to 1 intervention - of which BONGO DEVICE is the first listed.
NCT02878590 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT02878590 about?
NCT02878590 is a clinical study titled "Clinical Study for the BONGO Device in the Treatment of Obstructive Sleep Apnea (OSA)". Prospective, non-randomized, open label study
What is the current status of trial NCT02878590?
This trial is currently completed. It is a NA study. The enrollment target is 23 participants. The study started on 2016-09. Estimated completion is 2017-11-30.
What conditions does trial NCT02878590 study?
This clinical trial studies the following conditions: Obstructive Sleep Apnea.
What interventions are being tested in trial NCT02878590?
The interventions under investigation include: BONGO DEVICE (DEVICE).
Who is sponsoring clinical trial NCT02878590?
This trial is sponsored by InnoMed Healthscience, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02878590 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obstructive Sleep Apnea
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02878590's enrollment target sits among peer trials
23 134th of 155 higher than 21 of 155 other Obstructive Sleep Apnea trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Obstructive Sleep Apnea trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Impact of Positive Airway Pressure Therapy on Clinical Outcomes in Older Veterans With Chronic Obstructive Pulmonary Disease and Comorbid Obstructive Sleep Apnea (Overlap Syndrome)
RECRUITING · NA
-
Cognition After OSA Treatment Among Native American People (CATNAP)
RECRUITING · NA
-
Treatment of Obstructive Sleep Apnea With Personalized Surgery in Children With Down Syndrome (TOPS-DS)
RECRUITING · NA
-
Mandibular Advancement Device and Changes in Nocturia
RECRUITING · NA
-
Severe Label Expansion for EVO Products Trial
RECRUITING · NA
-
App-Based Optimization of Long-Term CPAP Adherence and Quality of Life
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03616041 · 23 participants
Capsule Endoscopy for Severe Hematochezia
- NCT04348747 · 23 participants · Phase 2
Dendritic Cell Vaccines Against Her2/Her3 and Pembrolizumab for the Treatment of Brain Metastasis From Triple Negative Breast Cancer or HER2+ Breast Cancer
- NCT04587687 · 23 participants · Phase 2
Brentuximab Vedotin and Bendamustine for the Treatment of Relapsed or Refractory Follicular Lymphoma
- NCT04715022 · 23 participants · Phase 1
Sympathetic-vascular Dysfunction in Obesity and Insulin Resistance (Vitamin C Study)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia